Fig. 1 · Structure

Documents & Downloads

Roniciclib (BAY 1000394)

Cat. No. A12742 CAS 1223498-69-8

CDK inhibitor

BAY 1000394 is an orally bioavailable cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity.

In Stock

Publications for Roniciclib

2 publications citing this product

  1. Marzia Ognibene, .et al. , Sci Rep, 2020, 10: 12902 PMID: 32737364
  2. Xinan (Holly) Yang, .et al. , Sci Rep, 2017, 7: 41 PMID: 28246384

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
Cdk1/cyclin B IC50 7 nM
CDK2/cyclinE IC50 9 nM
CDK4/cyclin D IC50 11 nM
CDK9/cyclinT1 IC50 5 nM
CDK7/Cyclin H/MAT1 IC50 25 nM

Cellular Effect

Cell Line Activity Value Description Reference
MCF7 IC50 15 nM Cytotoxicity against human MCF7 cells assessed as growth inhibition after 96 hrs [PMID: 26115571]
MCF7 IC50 16 nM Antiproliferative activity against human MCF7 cells after 4 days by crystal violet staining based assay [PMID: 30639897]
Sf21 IC50 25 nM Inhibition of recombinant human C-terminal His6-tagged full length CDK7/untagged recombinant full length human Cyclin H/N-terminal GST-tagged recombinant full length human MAT1 expressed in baculovirus infected Sf21 insect cells using cdk7 peptide as subs [PMID: 30543440]
Sf21 IC50 5 nM Inhibition of recombinant human full-length C-terminal His6-tagged CDK9/human full-length untagged cyclin T1 expressed in baculovirus infected Sf21 insect cells using PDKtide as substrate [PMID: 30543440]
Sf21 IC50 9 nM Inhibition of recombinant human full-length C-terminal His6-tagged CDK3/full-length human N-terminal GST-tagged Cyclin E expressed in baculovirus infected Sf21 insect cells using histone H1 as substrate [PMID: 30543440]
Sf9 IC50 < 10 nM Inhibition of recombinant human N-terminal thrombin cleavage site-fused/GST-tagged CDK2 (M1 to L298 residues)/Cyclin E1 (M1 to A395 residues) expressed in baculovirus infected Sf9 insect cells using histone 3s as substrate in presence of [gamma-33P] ATP [PMID: 30543440]
Sf9 IC50 7 nM Inhibition of recombinant human N-terminal GST/His6-tagged CDK1 (M1 to M297 residues)/Cyclin B1 (M1 to V433 residues) expressed in baculovirus infected Sf9 insect cells using histone 3s as substrate in presence of [gamma-33P] ATP [PMID: 30543440]
Sf9 IC50 7 nM Inhibition of human recombinant N-terminal GST/HIS6-tagged CDK1 (1 to 297 residues)/cyclin B1 (1 to 433 residues) expressed in baculovirus infected Sf9 insect cells using histone 3 as substrate by 33P-gamma ATP based assay [PMID: 27171036]
Sf9 IC50 7 nM Inhibition of recombinant CDK1/GST-fused cyclin B (unknown origin) expressed in baculovirus infected insect Sf9 cells by substrate phosphorylation assay in presence of [33P]-gamma adenosine triphosphate [PMID: 26115571]
Sf9 IC50 9 nM Inhibition of human recombinant full length N-terminal GST-tagged CDK2 (1 to 298 residues)/cyclin E1 (1 to 395 residues) expressed in Sf9 insect cells using histone 3 as substrate by 33P-gamma ATP based assay [PMID: 27171036]
Sf9 IC50 9 nM Inhibition of recombinant CDK2/GST-fused cyclin E (unknown origin) expressed in baculovirus infected insect Sf9 cells by substrate phosphorylation assay in presence of [33P]-gamma adenosine triphosphate [PMID: 26115571]

11 records · Scroll to view more

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 1223498-69-8
Applications CDK inhibitor
Formula C18H21F3N4O3S
Molecular Weight 430.44
Synonyms BAY10-00394
SMILES
C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc([S@](=N)(=O)C3CC3)cc2)ncc1C(F)(F)F

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Publications

2 publications citing this product

  1. Marzia Ognibene, .et al. , Sci Rep, 2020, 10: 12902 PMID: 32737364
  2. Xinan (Holly) Yang, .et al. , Sci Rep, 2017, 7: 41 PMID: 28246384

Added to your cart

View Cart Checkout
Loading...